2 Tabex - 200 Tablets

2 Tabex - 200 Tablets

TABEX QUIT SMOKING 100 TABLETS

STOP smoking with TABEX - it's easy!

A MODERN AND RELIABLE METHOD FOR GIVING UP SMOKING! 
FOR CLEAN LUNGS AND FOR A HEALTHY HEARTH!
STOP SMOKING WITH TABEX!

Quit smoking! Stop smoking with Tabex!

Quit smoking! Stop smoking with Tabex!

Quit smoking! Stop smoking with Tabex!

Tabex manifests one of the best results to date for the group of preparations, intended for tobacco smoking therapy.

Tabex® is an effective product for treatment of nicotine dependence in case of serious desire for smoking cessation. IT DOES NOT CONTAIN NICOTINE! Tabex® is an original Bulgarian product, trademark of Sopharma JSCo. Cytisine is the active substance of the medicinal product - an alkaloid contained in the plant leguminous tree (Cytisus laburnum L). Cytisine has structure and mechanism of action similar to those of nicotine and decreases its period of interaction with the specific receptors. Thus, it prevents the appearance of abstinence syndrome. The result is gradual decrease of the typical smokers' psychic and physical nicotine dependence and subsequent smoking cessation without undesirable effects. One film-coated tablet Tabex contains 1.5 mg cytisine. Tabex has an excellent safety profile: ■ Tabex® has very good tolerance and in therapeutic doses it does not cause anorexia, nausea and vomiting. ■ It does not affect the active drivers' attention and machine operating ■ It is not recommended only in high level hypertension, advanced atherosclerosis, pregnancy and breast-feeding

Contraindications: Tabex is contraindicated in arterial hypertension and advanced atherosclerosis.

Warning: The clinical studies with Tabex show that the Bulgarian drug is effective and well tolerated. The adverse effects are insignificant in case of adequate treatment according to the schedule and do not necessitate reduction of the dose and shortening the duration of the treatment. The physicians should warn the patients that the simultaneous administration of the drug and smoking could lead to aggravated adverse effects of nicotine (nicotine intoxication). The drug should be used in all cases when the patient has a hones and firm intention to give up smoking.

There is not sufficient clinical experience with Tabex administration to patients with ischemic heart disease, cardiac impairment, cerebrovascular diseases, obliterating arterial diseases, hyperthyroidism, diabetes mellitus, renal and hepatic insufficiency. The use of the drug of these categories of patients should be performed only after the potential benefit has been weighed against the possible risks.

Pregnancy and lactation: The intraovular application of Cytisine substance to hen embryos induced no embriotoxic and teratogenic effect within the limits of the single therapeutic doses. Higher doses of the drug lead to embryotoxic action. On the base of the experimental data obtained, Tabex is recommended (with Cytisine as the basic component) not to be taken by pregnant women, due to the potential risk of embryotoxic action in case of uncontrolled administration. The drug should not be administered during breast feeding.

Effect of the drug on drivers and machine operators: Tabex is considered safe and induces no changes in the physchophysical status, driving ability and machine operation.

Drug interactions: No data is available on undesired interactions between Tabex and other pharmaceuticals.

Overdose: Symptoms of nicotine intoxication are observed in Tabex overdose. The toxic effects are manifested in nausea, vomiting, pupil dilation, tachycardia, general weakness, clonic convulsions, paralysis of respiration. The communications of overdose with the drug are scarce. Lavage of the stomach, monitoring of respiration, arterial pressure and heart rate are initiated as in all cases of overdose. Infusion, reanimation is undertaken with saline and glucose solutions, anticonvulsants, cardiotonics, analeptics, etc. symptomatic agents.